| Download the amazing global Makindo app: ✅ Means NICE/National Guidelines 2026 compliant Android | Apple | |
|---|---|
| MEDICAL DISCLAIMER: Educational use only. Not for diagnosis or management. See below for full disclaimer. |
Related Subjects:
Pharmacology in the Elderly
Capacity in Older Adult
Role of Urinary Catheters in the Elderly
Constipation in the Elderly
Falls
Post Falls Assessment
DNACPR in the Older Person
Treatment Escalation Plans (TEP) in the Elderly
Caring for Patients with Dementia
Surgical Liaison in Older Patients Quality & Silver Trauma (UK)
Pharmacology in the Elderly
📅 4-Month Syllabus in Geriatric Medicine (For Doctors in Training)
Month 1: Foundations
Week 1 – Introduction & Core Concepts
🧬 Normal ageing reduces physiological reserve in cardiovascular, renal, respiratory & neurological systems.
📌 Example: ↓ baroreceptor sensitivity → orthostatic hypotension; ↓ renal GFR → drug dose adjustments.
⚖️ Distinguish ageing from disease (e.g. presbycusis = normal high-frequency loss, vs pathological sensorineural hearing loss).
🧠 Concept of “homeostenosis” → narrowing of the body’s ability to respond to stress.
🌍 UK population ≥85 years is the fastest growing group.
📌 ↑ demand for long-term care, frailty units, and palliative services.
📊 NHS Long Term Plan & British Geriatrics Society (BGS) guidance shape frailty pathways & integrated care models.
💷 Socioeconomic costs: falls, dementia, and polypharmacy are leading drivers of hospital admissions and health expenditure.
🩺 The cornerstone of geriatric medicine → integrates medical, psychological, functional & social domains.
📌 Shown in RCTs to reduce mortality, improve quality of life, and delay institutionalisation.
🧩 Key components: medical review, medication review, cognition, mood, mobility, nutrition, ADLs, social support.
💡 Remember: CGA is a process not an event - dynamic and repeated as patients’ needs change.
🤝 Core team = doctors, nurses, AHPs (PT, OT, SLT, dietitian), pharmacists, social workers, and carers.
📌 Adapt communication for hearing loss (clear voice, visual aids) and cognitive impairment (short phrases, orientation cues).
👨👩👧 Family & carers play a crucial role in decision-making, advanced care planning & discharge planning.
⚠️ Safeguarding: Always consider elder abuse, neglect, and capacity under the Mental Capacity Act.
🧓 Frailty = state of ↑ vulnerability due to cumulative decline across multiple systems.
�
Week 2 – Frailty, Falls & Bone Health
🧓 Two main approaches:
• Phenotype (Fried) → ≥3 of: weight loss, weakness (grip strength), exhaustion, slow walking speed, low activity.
• Deficit Accumulation (Rockwood CFS) → frailty as a spectrum, quantified by deficits in function, comorbidities, and cognition.
📌 Both predict ↑ risk of hospitalisation, institutionalisation & mortality.
💡 Teaching tip: CFS is quick for bedside use, Fried’s model more research-focused.
⚠️ Falls = leading cause of morbidity, mortality & loss of independence in older adults.
🔎 Causes are multifactorial → gait/balance impairment, polypharmacy (esp. sedatives, antihypertensives), postural hypotension, visual impairment, neuropathy.
📌 NICE recommends multifactorial risk assessment & tailored intervention (strength/balance training, home hazard modification, vision/hearing review, medication rationalisation).
💡 Always ask about “near-miss” falls as a red flag for future events.
🦴 Osteoporosis = low bone mass + microarchitectural deterioration → ↑ fracture risk.
💊 1st line: Bisphosphonates (e.g. Alendronate), plus calcium & Vit D supplementation.
🏃♀️ Lifestyle: weight-bearing exercise, smoking cessation, alcohol reduction.
📌 Assess falls risk & bone health together - many fragility fractures are fall-related.
💡 Use FRAX/QFracture for 10-year fracture risk assessment.
🚶 Timed Up & Go (TUG): >12 seconds = ↑ falls risk.
🧾 Berg Balance Scale: assesses static & dynamic balance.
🏥 Other bedside tools: Chair Stand Test, Gait Speed, Grip Strength.
📌 These help guide rehab, physio referral & safe discharge planning.
💡 Mobility = “6th vital sign” in geriatrics - document routinely.
Week 3 – Delirium & Cognition
🧠 Acute, fluctuating disturbance in attention & cognition (hours–days).
⚠️ Causes: infection, new drugs (esp. anticholinergics, opiates, benzodiazepines), pain, constipation, urinary retention, hypoxia, metabolic derangements.
📌 Reversible if trigger found early. Always look for infection + medication changes first.
💡 NICE recommends routine use of 4AT for screening in hospitalised older adults.
🧩 Alzheimer’s disease – insidious memory loss, hippocampal atrophy on MRI.
🌊 Vascular dementia – stepwise decline, focal neuro signs, link with strokes.
🎭 Lewy body dementia (LBD) – visual hallucinations, Parkinsonism, cognitive fluctuations; antipsychotics contraindicated (risk of neuroleptic sensitivity).
🗣️ Frontotemporal dementia (FTD) – early personality/behavioural change or expressive aphasia; memory relatively spared early.
📌 Tailor management: cholinesterase inhibitors for Alzheimer’s & LBD; vascular risk factor control in vascular dementia.
📋 Tools:
• AMTS (10 questions) – quick bedside screen, good for acute settings.
• MMSE – widely used, but ceiling effects & licensing issues.
• MoCA – more sensitive for mild cognitive impairment & executive dysfunction.
📌 Always interpret in context: age, education, culture & language can bias results.
💡 Screening tools are supportive, not diagnostic - always link back to history, collateral & functional impact.
Week 4 – Polypharmacy & Prescribing
🧪 Ageing → ↓ renal clearance (CKD-EPI more accurate than eGFR in frail adults), ↓ hepatic metabolism, ↑ fat:lean ratio (lipid-soluble drugs accumulate).
🧠 ↑ CNS drug sensitivity (opiates, benzos, anticholinergics).
📌 Golden rule: “Start low, go slow, but don’t stop too soon if benefit is likely.”
📝 STOPP = Screening Tool of Older Persons' Prescriptions (flags potentially inappropriate meds).
➕ START = Screening Tool to Alert to Right Treatment (identifies omissions, e.g. missing bisphosphonate in steroid users).
📌 NICE & BGS recommend structured reviews in frailty, care homes, and hospital discharge planning.
💊 Opiates: risk of falls, constipation, delirium.
💊 Anticoagulants: high bleeding risk vs stroke/VTE prevention; use HAS-BLED/CHA₂DS₂-VASc for balance.
💊 Sedatives & anticholinergics: worsen delirium, cognitive impairment, falls.
📌 Always review indication, dose, duration. Consider deprescribing if risks outweigh benefits.
📋 Brown bag review (ask patient to bring all meds, incl. OTC & herbal).
🔄 Check adherence & swallowing ability (liquid or dispersible formulations may help).
👵 Polypharmacy is not always inappropriate - aim for “appropriate polypharmacy” rather than numerical cut-offs.
Month 2: Common Clinical Problems
Week 5 – Mobility & Falls II
⚡ Syncope = transient loss of consciousness due to cerebral hypoperfusion (e.g. arrhythmia, orthostatic hypotension).
🤕 Falls = often mechanical or balance-related, without LOC.
📌 Key: ECG, lying/standing BP, collateral history (witness accounts often decisive). Holter monitoring if suspicion of arrhythmia.
🔑 Always ask about prodrome (dizziness, palpitations) vs trip/slip mechanism.
🧠 Motor triad = bradykinesia, rigidity, resting tremor.
🛑 Non-motor features (often more disabling): depression, constipation, REM sleep behaviour disorder, cognitive decline.
📌 Parkinsonism can be drug-induced (antipsychotics), vascular, or atypical syndromes (MSA, PSP).
🤝 MDT approach: physio (gait/balance), OT (home safety), speech therapy (dysarthria, swallow), PD nurse specialist.
💊 Levodopa responsiveness is a key diagnostic clue.
🧑⚕️ Thrombolysis & thrombectomy can be offered in ≥80s if functional baseline was good and time window criteria are met.
📌 NICE: Age alone is not a contraindication - assess pre-stroke mRS (Modified Rankin Score).
🛠️ Rehab planning = early mobilisation, swallow screen, mood/cognition assessment, and family involvement.
⚠️ Watch for complications: aspiration pneumonia, post-stroke depression, falls from hemiparesis/visual neglect.
Week 6 – Cardiovascular Disease
💉 Common in older adults; vascular stiffness raises systolic BP.
📌 NICE:
• Age <80 → target <140/90 mmHg.
• Age ≥80 → target <150/90 mmHg (unless frail or multimorbid).
⚠️ Be cautious of postural hypotension → measure lying & standing BP. Falls risk may outweigh benefit of tighter control.
💊 First-line often thiazide-like diuretics (e.g. indapamide) or calcium channel blockers in >55 yrs.
❤️ HFpEF (Heart Failure with preserved EF) predominates in older adults; often linked with hypertension, AF, obesity.
📌 Unlike HFrEF, evidence for mortality benefit of drugs is limited.
🎯 Focus: symptom control (diuretics for congestion), comorbidity optimisation, exercise rehab.
🔑 Polypharmacy common → review diuretics & renal function regularly.
🧠 Prognosis is poor but varies widely; frailty and comorbid burden drive outcomes.
🫀 Prevalence ↑ with age; major cause of embolic stroke in elderly.
📌 Anticoagulation:
• Use CHA₂DS₂-VASc to estimate stroke risk.
• Use HAS-BLED to estimate bleeding risk.
⚖️ Frail patients often under-anticoagulated due to falls risk, but stroke risk usually outweighs bleeding risk (even in fall-prone).
💊 DOACs (e.g. apixaban) now preferred over warfarin in most, but adjust dose for renal function and age.
Week 7 – Respiratory & Infection
📌 “Atypical” presentations: delirium, falls.
📌 Palliative input often needed.
📌 Always check lactate & urine output.
📌 Overdiagnosis is common pitfall.
Week 8 – Nutrition & Metabolism
📌 Directly impacts falls & mortality.
📌 Avoid hypoglycaemia at all costs.
📌 Screen at-risk patients.
📌 Ethical issues frequent.
Month 3: Complex Care & Subspecialty
Week 9 – Oncology & Haematology
🎗️ Common cancers: colorectal, breast, prostate, lung. Presentation may be subtle due to comorbidities or frailty.
📌 Screening: Controversial in ≥75s - balance early detection vs overdiagnosis, harms of colonoscopy, and limited life expectancy.
💊 Treatment tolerance: Chemotherapy & radiotherapy carry higher toxicity; renal/hepatic reserve and frailty scores (e.g. Rockwood) should guide decisions.
🧭 Goals-of-care: Discuss prognosis, quality of life, and patient preferences - shared decision-making is crucial in geriatric oncology.
👥 MDT input (oncology, geriatrics, palliative care) optimises both survival and comfort.
🩸 Common causes: Iron deficiency anaemia (IDA), anaemia of chronic disease (ACD), and bone marrow disorders (e.g. myelodysplasia).
📌 Always exclude GI blood loss (colorectal cancer, angiodysplasia, ulcers) in IDA.
🔬 Work-up: FBC, iron studies, B12/folate, reticulocyte count; consider bone marrow biopsy if unexplained.
⚠️ Anaemia worsens frailty, falls, and cognitive decline - treat even "mild" anaemia if symptomatic.
💊 Management: Iron replacement (oral/IV), treat underlying cause, consider ESAs in CKD, supportive transfusions if refractory.
Week 10 – Renal & Urology
📌 Don’t over-diagnose “CKD” in normal ageing.
📌 Major QoL issue, MDT input vital.
📌 Balance treatment vs comorbidity.
📌 Always review indication.Week 11 – Neurology & Psychiatry
📌 Complex drug titration + palliative overlap.
📌 SSRIs effective but monitor hyponatraemia.
📌 Advance planning essential.Week 12 – Ethics & Law
📌 Involve advocates if needed.
📌 Use ReSPECT forms.
📌 MDT responsibility.Month 4: Integration & Practice
Week 13 – Rehabilitation & Community
📌 Goal setting with patient/family.
📌 Interface medicine growing field.
📌 Prevents “bed-blocking”.Week 14 – Palliative & End-of-Life Care
📌 Use “just in case” meds.
📌 Focus on comfort.
📌 Bereavement care matters too.
Week 15 – Acute Geriatrics & Emergencies
📌 Always search for reversible causes.
📌 Improves outcomes.
📌 Consider functional baseline.
📌 Discuss ceilings of care early.Week 16 – Consolidation & Assessment
📌 Practise structured assessments.
📌 Develop teaching/leadership skills.
📌 Links practice to curriculum.
📌 Continuous learning is key.📌 Teaching Methods